RxDoctor Payments Data

Cynthia Witt, MD

Family Medicine · Bessemer City, NCNPI 1306914585

Payments from drug & device makers

$1,986in general payments, 2019–2025

Across 105 payments — averaging $18.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$472
  • Novo Nordisk$439
  • AstraZeneca$231
  • GSK$215
  • Boehringer Ingelheim$175
  • Astellas Pharma US Inc$133
  • plus $321 from 12 others

What the payments were for

  • Food & beverage$1,89195%
  • Education$955%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,986 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$1,694
Medicare patients
41
Services billed
188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$58,271
TrulicityDulaglutide41$57,140
OzempicSemaglutide41$45,561
Tresiba Flextouch U-200Insulin Degludec32$37,221
EliquisApixaban26$34,984
RybelsusSemaglutide18$25,350
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$14,705
Novolog FlexpenInsulin Aspart40$14,148
Tresiba Flextouch U-100Insulin Degludec31$13,374
SymbicortBudesonide/Formoterol Fumarate32$12,236
Lantus SolostarInsulin Glargine,hum.Rec.Anlog62$11,836
Combivent RespimatIpratropium/Albuterol Sulfate14$11,064
MyrbetriqMirabegron12$9,721
Humalog Kwikpen U-100Insulin Lispro22$6,833
Albuterol Sulfate HfaAlbuterol Sulfate196$6,660

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$439$70,91159 claims
GSKTrelegy Ellipta$215$58,27144 claims
Lilly USA, LLCTrulicity$87$57,14041 claims
AstraZenecaSymbicort$231$12,23632 claims
Boehringer IngelheimCombivent Respimat$175$11,06414 claims
Astellas Pharma US IncMyrbetriq$133$9,72112 claims
AbbVieSynthroid$472$1,04117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Bessemer City

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →